Single and multiple transgenic mice as models for Alzheimer's disease

Progress in Neurobiology

Volumn 61, Issue 3, 2000, Pages 305-312

  Van Leuven, Fred ^a  

^a Campus Gasthuisberg   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; PRESENILIN 1; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; COGNITION; DEMENTIA; GENE EXPRESSION; GENE OVEREXPRESSION; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC;

EID: 0034014950     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00055-6     Document Type: Review

References (17)

1. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzalez V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
2. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
3. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque H., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslop P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Medicine. 3:1997;67-72.
4. Dewachter, I., Moechars, D., Gilis, M., Kuiperi, C., Laenen, I., Van Dorpe, J., Checler, F., Vanderstichele, H., Van Leuven, F. Aging increased amyloid peptides and caused plaques in brain of old APP/london transgenic mice by a different mechanism than a mutant Presenilin-1 transgene (Submitted, 1999).
5. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
6. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends in Neurosc. 20:1997;154-159.
7. Holcomb L., Gordon M., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Medicine. 4:1998;97-100.
8. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
9. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci., USA. 94:1997;1550-1555.
10. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., van Den Haute C., Checler F., Godaux E., Cordell B., van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of Amyloid Precursor Protein in brain. J Biol Chem. 274:1999;6483-6492.
11. Moechars D., Gilis M., Kuiperi C., Laenen I., van Leuven F. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport. 9:1998;3561-3564.
12. Moechars D., Lorent K., Van Leuven F. Premature death in transgenic mice that overexpress mutant Amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience. 91:1999;819-830.
13. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274.
14. Selkoe D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends in Cell Biol. 8:1998;447-453.
15. Spittaels, K., Van den Haute, C., Van Dorpe, J., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Van Lommer, A., Loos, R., Van Leuven, F., 1999. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 6, 2153-2165.
16. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
17. Tesseur, I., Van Dorpe, J., Spittaels, K., Van Den Haute, C., Moechars, D., Van Leuven, F., 1999. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein Tau in the brain of transgenic mice. Am J Pathol (in press).